The influence of intra-alveolar pressure and respiratory mechanics on pulmonary hemodynamics has been extensively studied.' Rodbard has presented the view that bronchomotor tone is a prominent factor in the regulation of pulmonary blood flow,' but the effect of bronchoconstriction on pulmonary pressure and flow has, so far, been studied very little in humans.' If the pulmonary hypertension observed in patients with broncho-obstructive disease is to be ascribed, even in part, to the obstruction itself, then one should be able to influence cardiac output or pulmonary vascular resistance by administering agents known to produce bronchospasm.
The influence of intra-alveolar pressure and respiratory mechanics on pulmonary hemodynamics has been extensively studied.' Rodbard has presented the view that bronchomotor tone is a prominent factor in the regulation of pulmonary blood flow,' but the effect of bronchoconstriction on pulmonary pressure and flow has, so far, been studied very little in humans.' If the pulmonary hypertension observed in patients with broncho-obstructive disease is to be ascribed, even in part, to the obstruction itself, then one should be able to influence cardiac output or pulmonary vascular resistance by administering agents known to produce bronchospasm.
The present study was designed to demonstrate the effect of histamine on pulmonary hemodynamics in a group of hospital patients with chronic bronchitis, pulmonary emphysema, or other lung diseases associated with impaired ventilation. It was hoped that the drug would produce in these patients a disproportionate bronchoconstriction even in doses having only slight primary circulatory effect. Effects ranging from no bronchoconstriction to severe bronchoconstriction were anticipated, however, because of individual variation in homeostatic reflexes and bronchial musculature sensitivity to histamine. The observations presented here describe the circulatory and ventilatory changes produced by small doses of histamine in patients selected on the basis of having chronic pulmonary disease.
MATERIAL AND METHODS
Twenty-one ambulatory, male hospital patients with chronic pulmonary disease were studied. Spirometry and cardiac catheterization were performed on consecutive days before and after the subcutaneous injection of 0.6 to 0.8 mg. of histamine phosphate. All subjects had performed the ventilatory tests previously and were thus familiar with the procedures.
On the first day, vital capacity and maximum breathing capacity were measured with the patient supine on a bed gatched 30 degrees from the horizontal, and blood pressure was measured. After a satisfactory baseline record had been obtained, the histamine A five-minute sample of expired air (while the subject breathed room air) was obtained simultaneously with the slow withdrawal of blood samples from the femoral and proximal pulmonary arteries. The expired air was analyzed by the Scholander microanalysis technique, and the blood samples by the Roughton-Scholander method. Arterial carbon dioxide content was measured, using the Kopp-Natelson microgasometer, and arterial pH estimated at body temperature by means of a water-jacketed glass electrode and a Cambridge Research Model pH Meter. The carbon dioxide tension was determined from the Singer Hastings nomogram. Alveolar oxygen tension was calculated using the alveolar air equation, arterial oxygen tension read from the oxygen dissociation curve, and the alveolar-arterial oxygen tension gradient calculated from these data. Tables 2 to 4 show the observed effects of histamine on vital capacity, maximal breathing capacity, minute breathing volume, alveolar ventilation, heart rate, systemic, pulmonary artery, and pulmonary wedge pressures, cardiac output (expressed as cardiac index), total systemic and pulmonary arterial resistances, arterial oxygen saturation, arterial oxygen tension, alveolar-arterial oxygen tension gradient, and respiratory fluctuations in pulmonary artery systolic and diastolic pressures.
RESULTS
Evaluation of the results showed a statistically significant fall in vital capacity and maximal breathing capacity. The minute volume of ventilation increased in most cases. The alveolar ventilation did not, however, show any significant change in those cases in which it was measured.
The heart rate showed a significant increase, the systemic blood pressure, a fall. The fall in pulmonary artery pressure was also significant, while there was no significant change in pulmonary wedge pressure. Since the average increase in cardiac index from 4.11 to 4.45 liters per minute was not statistically significant, calculated systemic and pulmonary resistance dropped. There was a statistically significant increase both in systolic and diastolic pulmonary artery pressure respiratory fluctuations.
The blood gas studies showed a significant fall in arterial oxygen saturation, no changes in arterial carbon dioxide tension, and a significant increase in the alveolar-arterial oxygen tension gradient. No significant changes in oxygen capacity were noted. In nearly all patients a slight facial flush was observed after histamine, and about one-half of the patients experienced a mild headache. DISCUSSION 
Ventilation
Histamine in nontoxic doses has no effect on the mechanics of breathing in the normal subject. In patients with asthma or some types of chronic lung disease, however, it has a powerful bronchomotor action; the systemic effects of the drug in these patients are similar to those in the normal subject.6' A fall in vital capacity after histamine has been found in studies of asthmatic individuals.6 ""' An increase in respiratory minute volume," a decrease in lung compliance,'9 and an increase in airway resistance'8 have been observed in patients with chronic pulmonary disease. Our data agree with these observations. It should be noted, however, that in some of our patients the vital capacity did not fall more than 100 ml. or even increased after histamine; in only nine cases did the vital capacity decrease more than 10 per cent. Furthermore, maximal breathing capacity did not decrease in all of our patients. Alveolar ventilation did not show statistically significant changes in those cases in which it was calculated. A variable effect of histamine on ventilatory function, according to the severity of disease, has been observed by others.' The bronchoconstrictor effect of histamine in the dosage used was not demonstrated in all of our patients. Our purpose, however, was to use relatively small amounts of the drug in order to limit its systemic effect. There are reflexes which serve to maintain a steady state when bronchoconstriction occurs. Most notable are the presso-receptors of the lung which react to increased expiratory pressure by increasing inspiratory effort and the resting volume of the lung. This passively dilates the constricted bronchi; thus, in the intact human subject, bronchospasm may be elusive.
Since bronchoconstriction occurred in some of the patients and not in others, any consistent circulatory change must be unrelated to the bronchoconstricting effect of histamine.
Systemic circulation
The Histamine and pulmonary circulation in man | STORSTEIN, CALABRESI, NIMS, GRAY blood in the periphery, with reduction of the venous return and of the cardiac output.' However, independent of the doses used, the circulatory effects of histamine vary greatly in different species according to the method of administration and the organs primarily affected. Although the parameters of systemic circulation which were measured did not show impressive changes, there was a trend toward a lower peripheral resistance after histamine. A lower resistance could lead to peripheral pooling of blood and a consequent drop in cardiac output. This was prevented by a rise in heart rate, thus homeostatic reflexes make it difficult to evaluate, quantitatively, changes in any one function.
Pulmonary circulation
To our knowledge, direct measurements of the effect of histamine on the pulmonary circulation in humans have not been reported. Different results have been observed in animals of different species, but it would be unwise to transfer such observations to humans. In rodents the predominant effect of histamine is bronchoconstriction; in cats, arterial vasoconstriction. In recent observations from this laboratory,28 the intravenous injection of histamine in the anesthetized dog was found to induce an initial rise in pulmonary artery pressure, followed by a fall which was secondary to a drop in cardiac output. In the unanesthetized dog the increased pulmonary artery pressure has been interpreted as a passive result of an initial increase in venous return." '5 In the isolated dog lung preparation, histamine also causes pulmonary hypertension; the increased resistance is apparently due to pulmonary vein constriction.' The effects of the drug on the airway volume and on the pulmonary blood volume are apparently independent of one another.' In rigidly controlled experimental conditions, however, with the lungs perfused artificially in situ through two separate cannulas, bronchoconstriction was associated with an increase in resistance to flow. 8 Our findings in the pulmonary circulation were qualitatively similar to those in the systemic circulation. The wedge pressure showed no changes, suggesting that in our experiments pulmonary venous resistance did not increase. There were no significant changes in cardiac output, hence the hemodynamic effects of histamine on the pulmonary circulation are probably not passive results of its action on the systemic circulation. However, changes in distribution of blood may have occurred after the administration of histamine and between our consecutive measurements of cardiac output.
For the purpose of analysis of the circulatory effects of histamine, we have arbitrarily segregated those patients in whom the decrease in vital capacity was greater than 10 per cent. Although there are quantitative differences, the hemodynamic changes following administration of the drug in the subgroup of patients showing evidence of bronchoconstriction are essentially similar to those observed in the whole group. This suggests that, in our experiments, the bronchomotor effect of histamine has no measurable influence on the pulmonary arterial pressure.
The increased respiratory fluctuations in pulmonary arterial pressure have been interpreted as evidence of increased airway resistance.2'13 '14 In order to analyze the mechanism of the respiratory swing, it is necessary to remove the influence of the intrathoracic pressure itself from the measurement of vascular pressure. To accomplish this the intrathoracic pressure must be subtracted algebraically from the observed gross vascular pressure, thus providing a "net" pulmonary artery pressure. between the pulmonary artery pressure fluctuations of those patients who had evidence of bronchoconstriction and those who did not. and the pulmonary artery resistance decreased even in patients who showed bronchoconstriction; therefore, one must conclude that respiratory fluctuations do not reflect an effect of bronchoconstriction on pulmonary hemodynamics. Rather, it would appear, these fluctuations represent the algebraic sum of intrathoracic and intravascular pressure variations. This does not rule out the possibility that some types of bronchoconstriction could alter blood flow or resistance. The site of bronchial constriction or relaxation, whether involving primarily the large or small bronchi, must be determined if the relationship between bronchomotor tone and pulmonary hemodynamics is to be understood.9 However, the bronchospastic effect of histamine has been shown to be similar to that of true asthma.' In view of this, the present studies cast doubt on the role of bronchospasm as a cause of increased pulmonary vascular resistance leading to pulmonary hypertension in patients with chronic asthma.
4. Alveolar-arterial oxygen tension gradient A significant fall in arterial oxygen saturation was observed, but no change in arterial carbon dioxide tension. The alveolar-arterial oxygen tension gradient showed a rise. These changes in blood gas values have been reported by others,1' 178 who found a fall in arterial oxygen saturation after 1 to 1.5 mgm. of histamine in patients with heart and lung diseases. Tang' also observed a widening of the alveolar-arterial oxygen tension gradient following histamine. These workers were of the opinion that the observed changes in blood gas values were due to a thickening of the alveolar-capillary membrane.
The fall in arterial oxygen saturation seen in our patients was not produced by alveolar hypoventilation, as the arterial carbon dioxide tension was not elevated, nor was the alveolar ventilation changed after histamine. An increase in alveolar-arterial oxygen tension gradient might be due to a thickening of the alveolar-capillary membrane or an increase in venous admixture. Experiments have been carried out to study the possibility of venous admixture. After establishing the resting arterial oxygen saturation, patients were given 100 per cent oxygen to breathe following histamine administration. They all showed a rise in arterial oxygen saturation to 100 per cent during oxygen breathing. These experiments tend to exclude a venous admixture following histamine. Animal experiments showing an increase in lung weight following histaminel' suggest that the drug causes capillary dilatation, possibly also edema. This would increase the distance between the alveolar space and the hemoglobin and impair oxygen diffusion.
Transudation of plasma across the capillary wall and an increased concentration of hemoglobin have been noted by others, both in the systemic,"' and in the pulmonary circulation.17 This effect was not noted in our patients, however, possibly because of the low dose of histamine used. The influence of histamine on arterial oxygen saturation and tension has already been applied in a test attempting to augment borderline central cyanosis in patients with various disorders.' '16"7 One probable explanation for the widening of the alveolar-arterial oxygen tension gradient observed in the present study is that a disturbance occurred in the ventilation-to-perfusion ratio. If perfusion increased greatly while ventilation did not, the alveolar-arterial oxygen tension gradient might be expected to increase. Hypoventilation alone does not seem a likely cause of the phenomenon, since the arterial carbon dioxide tension did not rise, but rather fell after histamine.
SUMMARY
Twenty-one patients with various chronic lung diseases have been studied. Ventilation and pulmonary hemodynamics have been observed following the subcutaneous administration of histamine phosphate. A pronounced decrease in maximal breathing capacity and vital capacity occurred in nine.
There was an increase in heart rate, a fall in systemic blood pressure and peripheral arterial resistance, but no change in cardiac output. A vasodilator effect of histamine was also demonstrated in the pulmonary circulation, with a fall in pulmonary artery mean pressure and pulmonary arterial resistance, but no change in pulmonary arter-y wedge pressure. The increase in bronchomotor tone produced by histamine in some patients did not measurably influence the pressures or resistance in the pulmonary circulation. The concept that pulmonary hypertension may be the direct effect of bronchoobstructive disease cannot be supported by these findings.
Arterial oxygen saturation fell, but little change occurred in arterial carbon dioxide tension. The alveolar-arterial oxygen tension gradient rose. The latter was probably the result of capillary dilatation and alteration of the ventilation: perfusion relationship produced by histamine.
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